IMPEL NEUROPHARMA INC

Profile

Company Names

IMPEL NEUROPHARMA INC

Addresses

201 ELLIOTT AVE. W, SUITE 260, SEATTLE, WA 98119

201 ELLIOTT AVE. W, SUITE 260, SEATTLE, WA 98119

915 EAST PINE ST, SUITE 401, SEATTLE, WA 98122

720 BROADWAY AVE., SUITE 413, SEATTLE, WA 98122

867 SW SHOREMONT AVE, NORMANDY PARK, WA 98166

Phone Numbers

206-568-1466
408-966-9981

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$39,722,709.00

Number of Funding Rounds:

16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2021-03-18 
$0.00 
$1,932,000.00 
$1,932,000.00 
 
15
2021-03-05 
$7,500,000.00 
$7,500,000.00 
$0.00 
Debt 
14
2021-02-09 
$0.00 
$490,000.00 
$490,000.00 
 
13
2020-05-04 
$0.00 
$5,622,139.00 
$5,622,139.00 
 
12
2020-01-23 
$0.00 
$481,482.00 
$481,482.00 
 
11
2019-06-24 
$0.00 
$1,578,736.00 
$1,578,736.00 
 
10
2019-02-08 
$0.00 
$1,387,323.00 
$1,387,323.00 
 
9
2016-11-16 
$22,297,064.00 
$37,300,000.00 
$15,002,936.00 
Equity 
8
2016-09-28 
$80,000.00 
$80,000.00 
$0.00 
Debt 
7
2016-07-06 
$1,090,000.00 
$2,000,000.00 
$910,000.00 
Debt 
6
2015-09-03 
$4,000,000.00 
$12,000,000.00 
$8,000,000.00 
Equity 
5
2015-08-31 
$1,257,927.00 
$1,257,927.00 
$0.00 
Equity 
4
2013-11-12 
$2,640,025.00 
$3,796,960.00 
$1,156,935.00 
Equity 
3
2012-07-31 
$25,000.00 
$500,000.00 
$475,000.00 
Debt 
2
2011-09-07 
$527,329.00 
$1,999,999.00 
$1,472,670.00 
Equity 
1
2010-01-15 
$305,364.00 
$1,543,553.00 
$1,238,189.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADRIAN 
 
ADAMS 
DIRECTOR, EXECUTIVE OFFICER
ARALEZ PHARMACEUTICALS INC.   |  IMPEL NEUROPHARMA INC   |  ACELRX PHARMACEUTICALS INC   |  TALPHERA, INC.
DAVID 
 
ALLISON 
DIRECTOR
CETERIX ORTHOPAEDICS, INC.   |  IMPEL NEUROPHARMA INC   |  ALBAMUNITY, INC.   |  SOTERIA BIOTHERAPEUTICS, INC.   |  NEUROGASTRX, INC.   |  ARPEGGIO BIOSCIENCES, INC.
JON 
 
CONGLETON 
EXECUTIVE OFFICER, DIRECTOR
IMPEL NEUROPHARMA INC   |  MINERALYS THERAPEUTICS, INC.
MICHAEL 
 
HITE 
DIRECTOR
IMPEL NEUROPHARMA INC
MICHAEL 
P. 
HITE 
EXECUTIVE OFFICER, DIRECTOR
IMPEL NEUROPHARMA INC
RODNEY 
 
HO 
DIRECTOR
IMPEL NEUROPHARMA INC
JOHN 
D. 
HOEKMAN 
EXECUTIVE OFFICER, DIRECTOR
IMPEL NEUROPHARMA INC
JOHN 
 
LEAMAN 
EXECUTIVE OFFICER
INOTEK PHARMACEUTICALS CORP   |  IMPEL NEUROPHARMA INC   |  ARTHROSI THERAPEUTICS, INC.
ROBERT 
 
MITTENDORFF 
DIRECTOR
SILK ROAD MEDICAL INC   |  IMPEL NEUROPHARMA INC   |  NEOCIS, INC.   |  AVALYN PHARMA INC.   |  AKTANA, INC.   |  CAPITAL RX, INC.   |  CARLSMED, INC.   |  NALU MEDICAL, INC.   |  ATOMWISE INC.   |  VOLASTRA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  NUMERION LABS, INC.
TIM 
 
NELSON 
DIRECTOR
IMPEL NEUROPHARMA INC   |  FIDELITY FINANCIAL CORP   |  WESTERN STATES STORAGE PROPERTIES, LLC
STEWART 
 
PARKER 
DIRECTOR
NEXGENIA INC.   |  IMPEL NEUROPHARMA INC   |  STRIDEBIO, INC.
AARON 
 
ROYSTON 
DIRECTOR
IMPEL NEUROPHARMA INC   |  MENLO THERAPEUTICS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  AKERO THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  SWIFT HEALTH SYSTEMS INC.   |  RAYZEBIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  VENTYX BIOSCIENCES, INC.   |  NEUROGASTRX, INC.   |  MAREA THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.   |  ARPEGGIO BIOSCIENCES, INC.   |  CALDERA THERAPEUTICS, INC.
ALI 
 
SATVAT 
DIRECTOR
TRILOGY MEDWASTE, INC.   |  ACUFOCUS, INC.   |  CLARIFY HEALTH SOLUTIONS, INC.   |  IMPEL NEUROPHARMA INC   |  HEADLANDS RESEARCH, INC.   |  DIGITAL DIAGNOSTICS INC.   |  TREELINE BIOSCIENCES, INC.   |  PAIGE.AI, INC.   |  KKR COMET, LLC
MAHENDRA 
 
SHAH 
DIRECTOR
AVADHI FINANCE + TECHNOLOGY INC   |  CRINETICS PHARMACEUTICALS, INC.   |  VIVO PANDA FUND, L.P.   |  BOLT BIOTHERAPEUTICS, INC.   |  IMPEL NEUROPHARMA INC   |  HOMOLOGY MEDICINES, INC.   |  SOLENO THERAPEUTICS INC   |  CEREBRAL THERAPEUTICS, INC.   |  VERONA PHARMA PLC   |  SCIENTIA VASCULAR, INC.
DIANE 
 
WILFONG 
DIRECTOR
IMPEL NEUROPHARMA INC
JIM 
 
YOUNG 
DIRECTOR
INCLINE THERAPEUTICS, INC.   |  PORTAL INSTRUMENTS, INC.   |  IMPEL NEUROPHARMA INC   |  CHEATHAM STREET, LP   |  CANNAROYALTY CORP.   |  ELMIRA JV, LLC   |  SH127 LLC   |  SH-46 LLC   |  SH100, LLC   |  TL 99 LLC   |  SABOT DROPZONE LLC   |  SABOT SEGUIN ONE, LLC   |  ROCKPORT LANDING INVESTOR, LLC   |  M34 CAPITAL OPPORTUNITY FUND I, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-01
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-03-18 
2021-03-12
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-03-05 
2021-02-17
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-02-09 
2020-05-06
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-05-04 
2020-01-30
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-01-23 
2019-07-03
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-06-24 
2019-02-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2019-02-08 
2016-12-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16 
2016-10-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2016-09-28 
2016-08-29
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-06 
2015-09-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-03 
2015-09-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-31 
2013-11-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-12 
2012-08-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-31 
2011-09-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-07 
2010-01-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CASCADIA CAPITAL, LLC
101020
KEVIN CABLE
480071